Research shows vitamin D deficiency is strongly linked to uterine fibroids, and vitamin D appears to slow or shrink fibroid growth by stopping fibroid cells from multiplying and reducing hormone-driven growth. According to Gram Research analysis of a 2026 systematic review examining laboratory, animal, and human studies through July 2025, fibroid tissue consistently shows significantly lower vitamin D levels than healthy tissue, and vitamin D treatment reduced fibroid size in clinical trials without major side effects. While results are promising and suggest vitamin D could be a safe, affordable option for fibroid management, larger clinical trials are needed to establish optimal dosing and treatment guidelines.
Uterine fibroids are common noncancerous growths that affect many women and can cause heavy bleeding, pain, and fertility problems. According to Gram Research analysis, a new systematic review found that vitamin D deficiency is strongly linked to fibroid development, and vitamin D may help slow or shrink these growths. The research examined laboratory studies, animal research, and human clinical trials published through 2025. Scientists discovered that vitamin D works by stopping fibroid cells from multiplying and reducing damage to cell DNA. While results are promising and suggest vitamin D could be a safe, affordable alternative to surgery, researchers say larger clinical trials are needed to establish proper dosing and treatment guidelines.
Key Statistics
A 2026 systematic review published in Cureus found that uterine fibroid tissue is highly correlated with deficient vitamin D levels across laboratory, animal, and human clinical studies conducted through July 2025.
Laboratory studies included in the 2026 Cureus systematic review demonstrated that vitamin D exerts antiproliferative effects on fibroid cells, mitigates cellular DNA damage, and modulates estrogen and progesterone receptor expression.
Animal models examined in the 2026 systematic review showed high efficacy of vitamin D in suppressing fibroid growth, with human clinical trials supporting its role in regressing fibroid size and volume without causing significant adverse effects.
The 2026 Cureus review identified vitamin D as a safe, well-tolerated, and cost-effective therapeutic option for uterine fibroids, particularly for patients seeking fertility preservation or those deemed surgically unfit.
The Quick Take
- What they studied: Whether vitamin D deficiency causes uterine fibroids and if taking vitamin D could help shrink these growths or prevent them from forming.
- Who participated: The review analyzed multiple types of research: laboratory experiments with fibroid cells, animal studies, and human clinical trials. No single sample size applies since this combined many different studies published between inception and July 2025.
- Key finding: Fibroid tissue shows significantly lower vitamin D levels compared to healthy tissue, and vitamin D appears to stop fibroid cells from growing and may reduce fibroid size in both laboratory and animal studies.
- What it means for you: If you have fibroids or are at risk, maintaining adequate vitamin D levels through sunlight, food, or supplements may help prevent or slow fibroid growth. However, this should not replace medical care. Talk to your doctor before starting vitamin D supplements, especially if you’re considering surgery or fertility treatment.
The Research Details
This was a systematic review, which means researchers searched medical databases (PubMed Central and Google Scholar) for all published studies about vitamin D and uterine fibroids from the beginning of records through July 2025. They looked for three types of evidence: laboratory studies where scientists grew fibroid cells in dishes and tested vitamin D on them, animal studies where researchers gave vitamin D to animals with fibroids, and human clinical trials where real patients received vitamin D treatment.
The researchers carefully selected which studies to include based on strict rules. They only included peer-reviewed scientific papers written in English that directly studied vitamin D’s effects on fibroids. They excluded opinion pieces, conference presentations, and studies about other gynecological conditions. Two independent reviewers checked each study to make sure it met the requirements, and they discussed any disagreements until they agreed.
Because the studies used different methods and measured different outcomes, the researchers could not combine all the data into one statistical analysis. Instead, they summarized what each study found and looked for common patterns across all the research.
A systematic review is valuable because it gathers all available evidence on one topic, giving a complete picture rather than relying on single studies that might be limited or biased. By examining laboratory, animal, and human research together, scientists can understand both how vitamin D works at the cellular level and whether those effects actually help real patients. This approach helps identify whether vitamin D is truly effective and safe before recommending it widely.
The researchers used established tools to assess how reliable each study was, including the Cochrane Risk of Bias tool for human studies and specialized checklists for animal and laboratory research. The review followed PRISMA guidelines, which are international standards for conducting systematic reviews. However, because the studies used different methods and patient populations, the overall strength of evidence is moderate rather than definitive. The authors acknowledge that large-scale randomized controlled trials (the gold standard for medical research) are still needed to confirm vitamin D’s effectiveness and determine the best dosing.
What the Results Show
The research consistently showed that women and tissue samples with uterine fibroids have significantly lower vitamin D levels than those without fibroids. This strong correlation suggests vitamin D deficiency may contribute to fibroid development. Laboratory studies demonstrated that when scientists added vitamin D to fibroid cells grown in dishes, the vitamin D stopped the cells from multiplying and reduced their growth rate. Additionally, vitamin D reduced DNA damage in fibroid cells and changed how these cells responded to the hormones estrogen and progesterone, which are known to fuel fibroid growth.
Animal studies reinforced these laboratory findings. When researchers gave vitamin D to animals with fibroids, the treatment slowed fibroid growth and in some cases reduced fibroid size. Importantly, the animals tolerated vitamin D well with no serious side effects. The human clinical trials that have been conducted so far also support these findings, showing that patients who received vitamin D treatment experienced reductions in fibroid size and volume without significant adverse effects.
The research suggests vitamin D works through multiple mechanisms: it directly inhibits the proliferation of fibroid cells, protects cells from DNA damage, and modulates hormone receptor expression. This multi-pronged approach may explain why vitamin D appears effective across different study types.
The review identified vitamin D deficiency as one of several risk factors for fibroid development, alongside obesity, dark skin pigmentation, low number of pregnancies, premenopausal status, family history, and heavy alcohol use. This suggests that vitamin D deficiency alone does not cause fibroids but contributes to risk, particularly in combination with other factors. The research also highlighted that vitamin D may be especially valuable for patients who want to preserve fertility or who are not good candidates for surgery due to other health conditions.
This systematic review builds on earlier research suggesting a link between vitamin D and fibroids. Previous studies had shown the correlation between low vitamin D and fibroid presence, but this comprehensive review is among the first to synthesize evidence across laboratory, animal, and human research to explain the biological mechanisms. The findings align with growing evidence that vitamin D plays protective roles in many gynecological conditions and supports the emerging view that vitamin D deficiency is a modifiable risk factor for fibroids.
The main limitation is that most human clinical trials to date have been small and used different dosing schedules and treatment durations, making it difficult to determine the optimal vitamin D dose and treatment length. The review could not perform a meta-analysis (a statistical combination of all studies) because the studies were too different in design and methods. Additionally, most research has focused on vitamin D’s effects in laboratory and animal settings, with fewer large human trials. The review does not provide information about which patients would benefit most from vitamin D treatment or how to identify those most likely to respond. Finally, the studies included did not always account for other factors that influence fibroid risk, such as diet, exercise, and stress.
The Bottom Line
Based on current evidence, maintaining adequate vitamin D levels (typically 30 to 50 ng/mL of blood serum) appears beneficial for fibroid prevention and may help slow fibroid growth. This can be achieved through moderate sun exposure (10 to 30 minutes several times per week), eating vitamin D-rich foods like fatty fish and fortified dairy, or taking supplements. However, the evidence is not yet strong enough to recommend vitamin D as a replacement for standard fibroid treatments. Women with diagnosed fibroids should discuss vitamin D supplementation with their gynecologist before starting treatment. Confidence level: Moderate. The evidence is promising but requires larger clinical trials to establish definitive dosing and treatment protocols.
Women of reproductive age, particularly those with family history of fibroids, dark skin pigmentation, obesity, or vitamin D deficiency, should ensure adequate vitamin D intake. Women diagnosed with fibroids who want to avoid surgery or preserve fertility should discuss vitamin D with their doctor. Women who are pregnant or planning pregnancy should be especially attentive to vitamin D levels, as fibroids can complicate pregnancy. This research is less relevant for postmenopausal women, as fibroids typically shrink after menopause. Anyone with kidney disease or taking medications that affect vitamin D metabolism should consult their doctor before supplementing.
Based on animal and laboratory studies, vitamin D’s effects on fibroid cells occur relatively quickly at the cellular level. However, in human patients, changes in fibroid size typically take months to become apparent. Most clinical trials showing fibroid regression used treatment periods of 8 to 12 weeks or longer. Realistic expectations are that consistent vitamin D supplementation may slow fibroid growth within 2 to 3 months and produce measurable size reduction within 3 to 6 months, though individual results vary. Maintaining adequate vitamin D levels long-term appears important for sustained benefits.
Frequently Asked Questions
Does vitamin D deficiency cause uterine fibroids?
Vitamin D deficiency is strongly associated with fibroid development, but it is not the sole cause. Research shows fibroid tissue has significantly lower vitamin D levels than healthy tissue. Vitamin D deficiency appears to be one of several risk factors, alongside obesity, family history, and hormonal factors. Correcting deficiency may help prevent or slow fibroid growth.
How much vitamin D should I take if I have fibroids?
Current research does not yet establish a specific recommended dose for fibroid treatment. Most studies suggest maintaining blood vitamin D levels of 30 to 50 ng/mL through sunlight, food, or supplements. Start with 1000 to 2000 IU daily and have your doctor check blood levels every 3 months. Your gynecologist can recommend dosing based on your individual needs and test results.
Can vitamin D replace surgery for uterine fibroids?
Vitamin D shows promise for slowing fibroid growth and may help some patients avoid surgery, but current evidence is not strong enough to recommend it as a complete replacement for surgical treatment. Vitamin D works best as a preventive measure or complementary therapy. Discuss with your gynecologist whether vitamin D supplementation is appropriate for your specific situation and fibroid severity.
How long does it take for vitamin D to shrink fibroids?
Laboratory and animal studies show vitamin D effects on fibroid cells occur relatively quickly, but human fibroid regression typically takes months. Most clinical trials used treatment periods of 8 to 12 weeks or longer. Expect measurable changes in fibroid size within 3 to 6 months of consistent vitamin D supplementation, though individual results vary.
Is vitamin D safe for treating fibroids?
Yes, vitamin D appears to be safe and well-tolerated for fibroid management based on available clinical trials, with no significant adverse effects reported. However, excessive vitamin D supplementation can cause toxicity. Work with your doctor to determine appropriate dosing, and have blood levels monitored regularly to ensure you stay within safe ranges.
Want to Apply This Research?
- Log weekly vitamin D intake (sun exposure minutes, food sources, and supplement dosage) and monthly fibroid symptom severity using a 1 to 10 scale for bleeding, pelvic pain, and urinary symptoms. Track blood vitamin D levels every 3 months if supplementing.
- Set a daily reminder to take a vitamin D supplement at the same time each day, or schedule three 20-minute outdoor activities per week during midday hours. Log these activities in the app to build consistency. If using supplements, start with 1000 to 2000 IU daily and increase only under medical guidance.
- Create a monthly symptom diary tracking fibroid-related bleeding, pain, and quality of life. Compare scores month-to-month to identify trends. Request blood vitamin D testing every 3 months and log results in the app. Share this data with your healthcare provider at each visit to assess whether vitamin D supplementation is helping your specific situation.
This article summarizes research findings and is for educational purposes only. It does not constitute medical advice. Uterine fibroids are a medical condition requiring professional diagnosis and treatment. Do not start, stop, or change vitamin D supplementation without consulting your gynecologist or healthcare provider. Vitamin D supplementation may interact with certain medications or medical conditions. Blood vitamin D levels should be monitored by a healthcare provider. This research is preliminary and larger clinical trials are needed before vitamin D can be recommended as a standard fibroid treatment. Always discuss any new treatment approach with your healthcare team before implementation.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.